Head-to-head · WeighScore
FMmeds vs Voxy
The verdict
FMmeds takes it — 63.2/100 to 62.1/100, but only just.
FMmeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FMmeds is a Manhattan Beach-based DTC telehealth platform selling compounded semaglutide and tirzepatide co-formulated with vitamin B12, with no membership fee and a free initial visit billed only on approval. Voxy is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | FMmeds | Voxy |
|---|---|---|
| WeighScore | 63.2/100 | 62.1/100 |
| Grade | C | C |
| Scorecard rank | #260 | #280 |
| Semaglutide | $225/mo (all doses, compounded) | $179/mo (compounded) |
| Tirzepatide | $265/mo (all doses, compounded) | $299/mo (compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #260 · C
Strengths
- All 50 states plus DC covered, stated in the Terms
- Operating LLC and full Manhattan Beach, CA address disclosed
- Named 503A pharmacy partner (Manifest Pharmacy, Greer SC)
- Aggressive 12-month pricing — semaglutide $95/mo and tirzepatide $145/mo, at the low end of the market
- Flat pricing across all dose strengths — no dose-escalation surcharge
Where it loses points
- Compounded only — no FDA-approved Wegovy, Ozempic, Mounjaro, or Zepbound
- Publishes the FDA compounded-medication disclaimer (medication is not FDA-approved)
- Clinical network not separately named
- LegitScript Certified, but the specific ID isn't shown
- FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Graded #280 · C
Strengths
- Names both its compounding pharmacy (VialsRX, Houston TX) and its prescribing medical group (Arora Health & Aesthetics) — most name neither
- Publishes the full price ladder for both drugs across 1-, 3-, 6- and 12-month terms before you start the assessment
- One price covers the provider visit, medication, injection supplies, shipping and monthly check-ins — no separate membership fee
- True month-to-month option at $179 semaglutide / $299 tirzepatide with no commitment required
- Free assessment with no charge to see if you qualify, and no labs required to start
Where it loses points
- No terms of service anywhere on the site — /terms, /terms-of-service and /terms-of-use all return 404
- No refund policy published; the only stated commitment language is 'cancel anytime'
- Advertised 'Starting at $129/mo' is the 12-month prepay rate — month-to-month is $179 semaglutide and $299 tirzepatide
- No public list of states served; availability depends on where affiliated providers are licensed
- The prescribing nurse practitioner is not named — 'provider details available during your consultation'
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.